Puyang Oilfield General Hospital
1 clinical trials · Sponsor
◉ Watch Puyang Oilfield General Hospital
| Record | Firm | Date |
|---|---|---|
| Orelabrutinib in Combination With R2 Regimen for R/R CD20+ B-cell Lymphoma (NCT05014100) | Puyang Oilfield General Hospital | 2021-09-01 |
Track Puyang Oilfield General Hospital automatically
Every clearance here is in the API, with alerts when new ones post.